The diagnostic assessment of liver injury is an important step in the management of patients
with chronic liver disease (CLD). Although liver biopsy is the reference standard for the …

Chronic liver inflammation drives hepatic fibrosis, and current immunosuppressive, anti-
inflammatory, and anti-viral therapies can weaken this driver. Hepatic fibrosis is reversed …

Background & Aims While the gold standard in the assessment of liver fibrosis remains liver
biopsy, non-invasive methods have been increasingly used for chronic hepatitis B (CHB) …

Information on the stage of liver fibrosis is essential in managing chronic hepatitis C (CHC)
patients. However, most models for predicting liver fibrosis are complicated and separate …

Fibrosis is a common endpoint of clinical trials in chronic hepatitis C, and liver biopsy
remains the gold standard for fibrosis evaluation. However, variability in the distribution of …

Liver biopsy is an important part of the evaluation of patients with a variety of liver diseases.
Besides establishing the diagnosis, the biopsy is often used to assess the severity of the …

Background & Aims: The purpose of our study was to prospectively compare the success
rate and diagnostic accuracy of magnetic resonance elastography, ultrasound elastography …

Nonalcoholic steatohepatitis (NASH) is a significant form of chronic liver disease in adults
and children. The natural history of NASH ranges from indolent to end-stage liver disease …

Background/Aims: In chronic viral hepatitis, liver biopsy is performed for assessing disease
activity and fibrosis. In this study, we evaluated the impact of the size of liver biopsy on the …

The diagnosis of liver fibrosis has traditionally relied on liver biopsy. However, recent studies
have suggested that there can be up to a 33% error in the diagnosis of cirrhosis. In this …